Evidence map›Paper›PMID 24618810›Full record

ArticleViruses2014

Equilibrium and kinetics of Sin Nombre hantavirus binding at DAF/CD55 functionalized bead surfaces.

Tione Buranda, Scarlett Swanson, Virginie Bondu, Leah Schaefer, James Maclean, Zhenzhen Mo, Keith Wycoff, Archana Belle, Brian Hjelle

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Hantavirus entry: Perspectives and recent advances.Advances in virus research · 2019
    Article
  4. Article
  5. Article
  6. Low-affinity binding inMolecular biology of the cell · 2017
    Article
  7. Review
  8. Anti-infective immunoadhesins from plants.Plant biotechnology journal · 2015
    Review
  9. Blood Groups in Infection and Host Susceptibility.Clinical microbiology reviews · 2015
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Tione BurandaDepartment of Pathology, University of New Mexico School of Medicine, MSC08 4640, Albuquerque, NM 87131, USA. buranda@unm.edu.
Scarlett SwansonDepartment of Pathology, University of New Mexico School of Medicine, MSC08 4640, Albuquerque, NM 87131, USA. scswanson@salud.unm.edu.
Virginie BonduDepartment of Pathology, University of New Mexico School of Medicine, MSC08 4640, Albuquerque, NM 87131, USA. vbondu@salud.unm.edu.
Leah SchaeferPlanet Biotechnology Inc., 25571 Clawiter Road, Hayward, CA 94545, USA. lschaefer@planetbiotechnology.com.
James MacleanPlanet Biotechnology Inc., 25571 Clawiter Road, Hayward, CA 94545, USA. jmaclean@planetbiotechnology.com.
Zhenzhen MoPlanet Biotechnology Inc., 25571 Clawiter Road, Hayward, CA 94545, USA. zmo@planetbiotechnology.com.
Keith WycoffPlanet Biotechnology Inc., 25571 Clawiter Road, Hayward, CA 94545, USA. kwycoff@planetbiotechnology.com.
Archana BellePlanet Biotechnology Inc., 25571 Clawiter Road, Hayward, CA 94545, USA. abelle@planetbiotechnology.com.
Brian HjelleDepartment of Pathology, University of New Mexico School of Medicine, MSC08 4640, Albuquerque, NM 87131, USA. bhjelle@salud.unm.edu.
Planet Biotechnology (United States) · USUniversity of New Mexico · US

Funding

WOMEN'S CANCERS RESEARCH PROGRAMP30CA118100 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Yolanda Sanchez · 2005 to 2026
$57.1M
UNM TRAININGP50GM085273 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI LIDKE, KEITH A · 2009 to 2018
$26.1M
Spatiotemporal Regulation of Membrane Raft Trafficking in Virus Activated CellsR03AI092130 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI BURANDA, TIONE · 2011 to 2012
$151k
Development of HTS Assays for Inhibitors of Viral-Cell InteractionsR21NS066429 · NINDS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI BURANDA, TIONE · 2010 to 2010
$151k
NCI NIH HHS P30 CA118100NCI NIH HHS P30 CA118100-08S2NIAID NIH HHS R03 AI092130NIGMS NIH HHS 1P50 GM085273NIGMS NIH HHS P50 GM085273NINDS NIH HHS R21 NS066429
6 · The paper itself

Abstract

Decay accelerating factor (DAF/CD55) is targeted by many pathogens for cell entry. It has been implicated as a co-receptor for hantaviruses. To examine the binding of hantaviruses to DAF, we describe the use of Protein G beads for binding human IgG Fc domain-functionalized DAF ((DAF)₂-Fc). When mixed with Protein G beads the resulting DAF beads can be used as a generalizable platform for measuring kinetic and equilibrium binding constants of DAF binding targets. The hantavirus interaction has high affinity (24-30 nM; k(on) ~ 10⁵ M⁻¹ s⁻¹, k(off) ~ 0.0045 s⁻¹). The bivalent (DAF)₂-Fc/SNV data agree with hantavirus binding to DAF expressed on Tanoue B cells (K(d) = 14.0 nM). Monovalent affinity interaction between SNV and recombinant DAF of 58.0 nM is determined from competition binding. This study serves a dual purpose of presenting a convenient and quantitative approach of measuring binding affinities between DAF and the many cognate viral and bacterial ligands and providing new data on the binding constant of DAF and Sin Nombre hantavirus. Knowledge of the equilibrium binding constant allows for the determination of the relative fractions of bound and free virus particles in cell entry assays. This is important for drug discovery assays for cell entry inhibitors.

Indexed as

Virus AttachmentCD55 AntigensHumansMicrospheresReceptors, VirusSin Nombre virusCD55 AntigensReceptors, Virus

Identifiers

PMID24618810
PMCPMC3970141
OpenAlexW1970467465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.